Peach and Lily just launched a Glass Skin Luminizing Stick, and we reviewed it. Check out the verdict and see photos here.

Eli Lilly & Co. (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. Its products span oncology, ...

These growth stocks come from two very different industries. Eli Lilly is riding the GLP-1 drug wave, but there is much more ...

If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...

NVO's fourth-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially Wegovy, Ozempic and Rybelsus. Here's why they view Eli Lilly (NYSE ...

We recently compiled a list of the 12 Best Big Name Stocks to Invest in Now. In this article, we are going to take a look at ...

I toss my sweaty workout clothes in the hamper with the rest of my laundry and let them sit until wash day. But lately, even ...

Lilly has been under pressure in the US over its pricing for insulin products, and earlier this ... who heads Lilly’s connected care and insulins programme. Bundling in Dexcom’s CGM tech ...

The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog ... head of connected care for Lilly Diabetes. "Using the learnings from early adopters of Tempo ...

Health-care companies rose after strong earnings from one obesity-drug maker. Eli Lilly shares rose after it reiterated its forecast for 32% 2025 revenue growth, amid rising demand for its Zepbound ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular ...